6533b838fe1ef96bd12a491f
RESEARCH PRODUCT
Helical Tomotherapy® is a safe and feasible technique for total scalp irradiation
Antonio Lo CastoA. PalmeriVanessa FigliaMariella ManninoFrancesco VerderameFrancesco CucciaGiuseppe Ferrerasubject
Histologymedicine.medical_treatmentPlanning target volumeCase ReportDose distributionTomotherapylcsh:RC254-282Tomotherapy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineTomotherapy IGRT IMRT Scalp irradiation AngiosarcomamedicineAngiosarcomaAngiosarcomaIMRTIGRTImage-guided radiation therapyExtensive Diseaseintegumentary systembusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.anatomical_structureOncologyHomogeneous030220 oncology & carcinogenesisScalpScalp irradiationNuclear medicinebusinessdescription
Angiosarcoma of the scalp is a rare aggressive tumor that affects elderly patients. Chemoradiation is the treatment of choice for multicentric and extensive disease. The shape of the scalp represents a dosimetric challenge in terms of achieving a homogeneous concave dose distribution with coverage of the entire target volume and an acceptable organs-at-risk sparing. We report a case of an 81-year-old man with a multifocal angiosarcoma of the scalp treated with Helical TomoTherapy® (Accuray Inc., Sunnyvale, CA, USA) intensity modulated radiotherapy. This technique allows precise and daily verifiable coverage of the target keeping the dose to the organs at risk within the constraints.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-03-01 | Rare Tumors |